A groundbreaking new study published in Nature analyzed tumor DNA from over 800 never-smokers, revealing shocking connections ...

Lurbinectedin plus atezolizumab significantly reduced the risk of disease progression or death by 46% compared with atezolizumab alone.

The FDA granted fast track status to DB-1310, a HER3-targeting antibody-drug conjugate, for advanced nonsquamous non-small cell lung cancer.

Non-small cell lung cancer (NSCLC) develops in lung tissues, but when it's metastatic, it has spread to distant areas of the ...

(The Hill) – Exposure to air pollution, other contaminants and traditional herbal medicines may be contributing to the development of lung cancer in people who have little or no history of smoking, a ...

Early-stage lung cancer sometimes causes finger clubbing, a harmless symptom that usually resolves when the cancer is treated.

The aim is to find and treat lung cancers early, before they grow and spread, to improve the chance of survival. Here’s what’s involved.

(WJAR) — Every year, at least 125,000 people die from lung cancer. Smoking, we know, is the number one cause of lung cancer "There's a stigma attached to lung cancer." said Dr. Terence Healey ...

Lung cancer remains the world’s deadliest cancer, and cigarette smoke is its chief culprit. Chemicals in tobacco, such as polycyclic aromatic hydrocarbons (PAHs), damage DNA and trigger the ...

Adding immunotherapy to chemotherapy before surgery for patients with operable non-small cell lung cancer—the leading cause of cancer deaths worldwide—improved long-term survival overall compared with ...

Lung cancer risk in never-smokers predicted by AI tool 'Sybil' An estimated 57% of Asian-American women diagnosed with lung cancer have never smoked, compared to only about 15% of all other women.

Jaclyn Keely was diagnosed with Stage 1 mucinous adenocarcinoma and had the lower lobe of her left lung removed last fall. She is running the RBC Brooklyn Half Marathon on Saturday.